Grape seed extract is a concentrated dry powder derived from the seeds of Vitis vinifera grapes, standardised for oligomeric proanthocyanidins (OPCs) — a class of polyphenol with well-documented antioxidant activity in laboratory settings. In human trials, doses ranging from 150mg to 300mg daily have been studied in contexts including venous insufficiency and oxidative stress. Large-scale RCT data in healthy adults remains limited, so I'll be straight about where the evidence is strong and where it thins out considerably.
What is Grape Seed Extract?
Grape seed extract is produced by cold-pressing grape seeds, then concentrating the resulting material into a dry extract powder. The active constituents are oligomeric proanthocyanidins — chains of catechin and epicatechin units that give red wine its astringency and grape seeds their bitter taste. In supplement form, a good-quality dry extract is typically standardised to contain 95% or more OPCs by weight, which is what distinguishes a genuine extract from a simple ground-seed powder.
OPCs sit within the broader flavonoid family of plant compounds. In human biology they're absorbed in the small intestine, partially metabolised by gut bacteria into smaller phenolic acids, and then circulated in the bloodstream. Their primary proposed mechanism is scavenging of reactive oxygen species — unstable molecules that may damage cell membranes, proteins and DNA when they accumulate in excess. They also appear to interact with enzymes involved in collagen cross-linking, which is one reason the venous health literature has paid them particular attention.
It's worth being clear about what grape seed extract is not. It has no approved health claim on the EU or UK Nutrition and Health Claims Register. That doesn't mean the research is worthless — it means the evidence base hasn't yet met the regulatory threshold for a specific claim. I think that's an honest place to start.
Clinical Evidence
The most consistent human evidence for grape seed extract sits in the area of chronic venous insufficiency — a condition where leg veins struggle to return blood efficiently to the heart, causing swelling, heaviness and discomfort. A Cochrane-style systematic review by Martinez-Zapata et al. (2020) examined phlebotonics, a class of plant-derived compounds that includes OPC-rich grape seed extract, across multiple RCTs. The review found that phlebotonics may reduce oedema and some symptoms of venous insufficiency compared with placebo, though the authors noted the overall quality of evidence was low to moderate. An earlier iteration of the same review by Martinez-Zapata et al. (2016) reached broadly similar conclusions, and an even earlier version by Martinez et al. (2005) flagged the same pattern — modest positive signals, methodological limitations, need for better-powered trials. That's three decades of Cochrane scrutiny pointing in the same direction, with the same caveat about evidence quality. Make of that what you will.
On the antioxidant and anti-inflammatory side, a 2017 narrative review by Weseler et al. (2017) specifically examined Masquelier's original OPC formulation — one of the best-characterised grape seed extracts — and concluded that it may support antioxidant defence in the circulation, with some human data suggesting measurable reductions in oxidised LDL markers. The review was careful to note that most human studies were small and short-term. More recently, Eshaghian et al. (2026) published findings on grape seed extract supplementation and inflammatory biomarkers, with some evidence that OPC supplementation may be associated with changes in oxidative stress markers — though again, study sizes were modest and the authors called for larger trials before firm conclusions could be drawn.
The glycation angle is interesting but early. A systematic review by Coelho et al. (2023) examined whether grape polyphenols might affect glycation markers — proteins damaged by excess glucose — and found some preliminary evidence from human and animal studies that grape-derived polyphenols may be associated with lower glycation endpoints. The authors were appropriately cautious: the human data is thin, heterogeneous, and not yet sufficient to draw clinical conclusions.
Animal data from Meeprom et al. (2011) showed that grape seed extract supplementation may improve insulin signalling in high-fructose-fed rats, with measurable differences in insulin receptor substrate phosphorylation. I include this because it's mechanistically interesting, but I want to be explicit: rat models of diet-induced insulin resistance don't translate cleanly to healthy human adults, and I wouldn't lean on this study to make a human efficacy claim.
There's also emerging dental and periodontal research worth mentioning. Abdulla et al. (2025) conducted a meta-analysis on antioxidant adjuncts in periodontal health in type 2 diabetes patients, finding that antioxidant supplementation — including grape-derived polyphenols — may be associated with some periodontal health markers. A narrative review by Gawish et al. (2024) similarly noted potential for phytotherapy including OPCs in periodontal contexts, and Thomas et al. (2025) flagged grape seed-derived compounds among nonfluoridated remineralising candidates. These are early-stage findings in specific clinical populations — not a basis for broad claims about dental health in healthy adults.
Dosage: What Research Supports
The clinical literature on grape seed extract uses a fairly wide dose range. Studies on venous insufficiency have typically used 150mg to 300mg of standardised OPC extract daily, often split across two doses. The Cochrane reviews referenced above don't specify a single optimal dose, partly because the included trials used different products, different standardisations, and different durations. That's a genuine limitation when trying to pin down a precise evidence-based recommendation.
EFSA has not established a dietary reference value for OPCs or grape seed extract, and the NHS doesn't issue a recommended daily intake for this ingredient. In the absence of a formal reference value, the practical benchmark I use is the dose range that appeared in the better-conducted human trials — which puts 150mg to 300mg as a reasonable working range for a standardised dry extract. There's no strong evidence that doses above 300mg confer additional benefit in healthy adults, and very high doses (above 2,400mg in some case reports) have been associated with adverse effects, though that's well above anything used in standard supplements.
KōJō Daily Formula provides 200mg of dry extract powder per serving. That sits comfortably within the range used in the venous insufficiency and antioxidant trials, without pushing into territory where the risk-benefit calculation becomes uncertain. It's not the highest dose on the market — deliberately so.
How KōJō Uses Grape Seed Extract
I chose dry extract powder specifically because it's the form used in the majority of the characterised human research, including the Cochrane-reviewed venous insufficiency trials. Standardised dry extract gives a predictable OPC content per capsule, which matters when you're trying to replicate something close to a studied dose. A whole-grape powder or an unstandardised product might contain wildly variable amounts of active compound from batch to batch — that's not something I'm willing to accept in a formula I take myself every day. The 200mg dose in KōJō Daily Formula is formulated alongside vitamin C, which some research suggests may support the recycling of oxidised flavonoids back to their active forms — though I'd describe that as mechanistically plausible rather than definitively proven in humans at these doses.
Grape seed extract is ingredient seven of 42 in the Daily Formula. It's not the headline act. I include it because the antioxidant evidence — while not spectacular — is reasonably consistent across multiple study designs, the dose is well-tolerated, and the cost-to-evidence ratio makes sense within a broad daily formula. I wouldn't build a standalone product around it at this stage of the evidence base.
Safety and Considerations
At doses used in clinical research (up to around 300mg daily), grape seed extract is generally well-tolerated in healthy adults. The most commonly reported side effects are mild and include headache, dizziness, and gastrointestinal discomfort. These appear to be dose-dependent and typically resolve on discontinuation. One area that warrants genuine attention is drug interaction: Wanwimolruk et al. (2015) identified that grape-derived compounds may interact with cytochrome P450 enzymes — particularly CYP3A4 — which are responsible for metabolising a significant proportion of prescription medications. If you're taking anticoagulants, statins, or any medication with a narrow therapeutic window, this is worth discussing with your GP or pharmacist before adding grape seed extract to your routine.
Consult a healthcare professional before starting grape seed extract if you are pregnant, breastfeeding, taking medication, or have an underlying condition. KōJō Daily Formula provides 200mg of dry extract powder per serving — stay within the single-serving guidance. People with grape allergies should avoid this ingredient entirely. There is currently insufficient safety data to recommend grape seed extract supplements during pregnancy.
Frequently asked questions
What does grape seed extract do?
Grape seed extract is a concentrated source of oligomeric proanthocyanidins (OPCs), plant polyphenols that may act as antioxidants in the body. Some human trials suggest it may be associated with modest benefits for venous circulation and oxidative stress markers, though Martinez-Zapata et al. (2020) note that overall evidence quality remains low to moderate.
How much grape seed extract should I take per day?
Human RCTs have typically used between 150mg and 300mg of standardised dry extract daily. There is no EFSA or NHS reference value for this ingredient. KōJō Daily Formula provides 200mg per serving, which sits within the range studied in the better-conducted trials. Staying within that range seems sensible given the current evidence.
Is grape seed extract safe?
At doses up to around 300mg daily, grape seed extract appears to be well-tolerated in healthy adults, with mild gastrointestinal discomfort the most commonly reported issue. However, Wanwimolruk et al. (2015) identified potential interactions with CYP450 enzymes, so anyone on prescription medication should check with a healthcare professional first.
How long does grape seed extract take to work?
Venous insufficiency trials have typically run for four to twelve weeks before measuring outcomes. There's no reliable data on how quickly antioxidant effects might be detectable in healthy adults. It's reasonable to assume that any observable effects, if they occur, would take several weeks of consistent daily use to become apparent.
Can I take grape seed extract every day?
Most clinical trials have used daily dosing without reported safety concerns in healthy adults over periods of up to twelve weeks. Longer-term safety data is limited. Daily use at a moderate dose — such as 200mg — appears reasonable for most healthy adults, but anyone with an existing health condition or on medication should seek advice before doing so.
What's the best form of grape seed extract?
Standardised dry extract powder, with a defined OPC content (typically 95% proanthocyanidins by weight), is the form used in the majority of human clinical research, including the trials reviewed by Weseler et al. (2017). Unstandardised whole-grape powders offer no reliable guarantee of active compound content per dose.
This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.
